Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Peng Cheng

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|January 20, 2024
Concerns about the ALIFE2 trialLiang V Tang, Zhi-Peng Cheng, Yu Hu
Medcomm|April 15, 2024
Tofacitinib for elderly onset hemophagocytic lymphohistiocytosis with gene mutations: a case reportTingting Liu, Zhi-Peng Cheng, Yu Hu, et al.
The International Journal of Oral & Maxillofacial Implants|March 3, 2011
Mechanical and histomorphometric evaluations of rough titanium implants treated with hydrofluoric acid/nitric acid solution in rabbit tibiaFu-Ming He, Guo-Li Yang, Shi-Fang Zhao, et al.
Scientific Reports|September 8, 2016
Air pollution and venous thrombosis: a meta-analysisLiang Tang, Qing-Yun Wang, Zhi-Peng Cheng, et al.
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|April 27, 2013
[Infantile fibrosarcoma: a case report]Zhi-Peng Cheng, Wei Feng, Shu-Qiang Li, et al.
Scientific Reports|April 26, 2016
A genetic analysis of 23 Chinese patients with hemophilia BQing-Yun Wang, Bei Hu, Hui Liu, et al.
F1000Research|February 10, 2015
APOC3 may not be a predictor of risk of ischemic vascular disease in the Chinese populationLiang Tang, Zhi-Peng Cheng, Qing-Yun Wang, et al.
Acta Pharmacologica Sinica|August 2, 2022
Adiponectin receptor agonist AdipoRon modulates human and mouse platelet functionXiang-Hui Zhou, Zhi-Peng Cheng, Meng Lu, et al.
Thrombosis Research|December 8, 2014
Lack of association between Factor V Hong Kong and Venous thrombosis in the Chinese populationZhi-Peng Cheng, Liang Tang, Hui Liu, et al.
Environmental Technology|October 19, 2020
Fabrication of attapulgite-based dual responsive composite hydrogel and its efficient adsorption for methyl violetYi-Xin Liu, Hui Zhong, Xiao-Rong Li, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|January 20, 2024
Concerns about the ALIFE2 trialLiang V Tang, Zhi-Peng Cheng, Yu Hu
Medcomm|April 15, 2024
Tofacitinib for elderly onset hemophagocytic lymphohistiocytosis with gene mutations: a case reportTingting Liu, Zhi-Peng Cheng, Yu Hu, et al.
The International Journal of Oral & Maxillofacial Implants|March 3, 2011
Mechanical and histomorphometric evaluations of rough titanium implants treated with hydrofluoric acid/nitric acid solution in rabbit tibiaFu-Ming He, Guo-Li Yang, Shi-Fang Zhao, et al.
Scientific Reports|September 8, 2016
Air pollution and venous thrombosis: a meta-analysisLiang Tang, Qing-Yun Wang, Zhi-Peng Cheng, et al.
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|April 27, 2013
[Infantile fibrosarcoma: a case report]Zhi-Peng Cheng, Wei Feng, Shu-Qiang Li, et al.
Scientific Reports|April 26, 2016
A genetic analysis of 23 Chinese patients with hemophilia BQing-Yun Wang, Bei Hu, Hui Liu, et al.
F1000Research|February 10, 2015
APOC3 may not be a predictor of risk of ischemic vascular disease in the Chinese populationLiang Tang, Zhi-Peng Cheng, Qing-Yun Wang, et al.
Acta Pharmacologica Sinica|August 2, 2022
Adiponectin receptor agonist AdipoRon modulates human and mouse platelet functionXiang-Hui Zhou, Zhi-Peng Cheng, Meng Lu, et al.
Thrombosis Research|December 8, 2014
Lack of association between Factor V Hong Kong and Venous thrombosis in the Chinese populationZhi-Peng Cheng, Liang Tang, Hui Liu, et al.
Environmental Technology|October 19, 2020
Fabrication of attapulgite-based dual responsive composite hydrogel and its efficient adsorption for methyl violetYi-Xin Liu, Hui Zhong, Xiao-Rong Li, et al.
Pageof 2